MENU
+Compare
STIM
Stock ticker: NASDAQ
AS OF
Jan 17 closing price
Price
$2.46
Change
+$0.18 (+7.89%)
Capitalization
141.64M

STIM Neuronetics Forecast, Technical & Fundamental Analysis

a developer of non-invasive therapies for psychiatric and neurological disorders

STIM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for STIM with price predictions
Jan 08, 2025

STIM in -4.46% downward trend, falling for three consecutive days on January 08, 2025

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where STIM declined for three days, in of 311 cases, the price declined further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for STIM moved out of overbought territory on January 02, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 35 similar instances where the indicator moved out of overbought territory. In of the 35 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 48 cases where STIM's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The Aroon Indicator entered an Uptrend today. In of 225 cases where STIM Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. STIM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.212) is normal, around the industry mean (23.424). P/E Ratio (0.000) is within average values for comparable stocks, (83.627). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (1.944) is also within normal values, averaging (41.167).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. STIM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.

View a ticker or compare two or three
STIM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

STIM is expected to report earnings to fall 45.16% to -24 cents per share on March 11

Neuronetics STIM Stock Earnings Reports
Q4'24
Est.
$-0.24
Q3'24
Missed
by $0.21
Q2'24
Missed
by $0.06
Q1'24
Beat
by $0.02
Q4'23
Beat
by $0.07
The last earnings report on November 12 showed earnings per share of -43 cents, missing the estimate of -23 cents. With 650.20K shares outstanding, the current market capitalization sits at 141.64M.
A.I. Advisor
published General Information

General Information

a developer of non-invasive therapies for psychiatric and neurological disorders

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
3222 Phoenixville Pike
Phone
+1 610 640-4202
Employees
203
Web
https://www.neurostar.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MSEQX59.681.02
+1.74%
Morgan Stanley Inst Growth I
AMAJX11.080.08
+0.73%
American Century Small Cap Dividend R
FTVZX34.840.19
+0.55%
FullerThaler Behav Md-Cp Val R6
PCSVX17.770.08
+0.45%
PACE Small/Medium Co Value Equity P
CCCAX6.970.03
+0.43%
Center Coast Brookfield Midstream Foc A

STIM and Stocks

Correlation & Price change

A.I.dvisor tells us that STIM and DIZTF have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that STIM and DIZTF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STIM
1D Price
Change %
STIM100%
+7.89%
DIZTF - STIM
31%
Poorly correlated
N/A
FNA - STIM
27%
Poorly correlated
+2.06%
NEO - STIM
26%
Poorly correlated
+1.65%
ACRS - STIM
25%
Poorly correlated
+2.39%
IART - STIM
24%
Poorly correlated
+3.70%
More